Drug Type Small molecule drug |
Synonyms SB 210313, SB-210313 |
Target |
Action inhibitors |
Mechanism 5-LOX inhibitors(Arachidonate 5-lipoxygenase inhibitors), COX-1 inhibitors(Cyclooxygenase-1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H23FN4O |
InChIKeyANWALZPQHPAZFO-UHFFFAOYSA-N |
CAS Registry165806-09-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Arthritis | Preclinical | United States | 27 Sep 1996 | |
Rheumatoid Arthritis | Discovery | United Kingdom | - |